Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion in Patients with Prior Treatment with Bevacizumab or Ranibizumab

被引:0
|
作者
van Zyl, Tave [1 ]
Papakostas, Thanos D. [1 ]
Lim, Laurence Shen [1 ,2 ]
Miller, John B. [1 ]
Husain, Deeba [1 ]
Eliott, Dean [1 ]
Kim, Leo A. [1 ]
机构
[1] Massachusetts Eye & Ear Infirm, Ophthalmol, Boston, MA 02114 USA
[2] Singapore Natl Eye Ctr, Ophthalmol, Singapore, Singapore
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
4623
引用
收藏
页数:2
相关论文
共 50 条
  • [41] RETINAL SENSITIVITY AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION
    Yamaike, Noritatsu
    Tsujikawa, Akitaka
    Sakamoto, Atsushi
    Ota, Masafumi
    Kotera, Yuriko
    Miyamoto, Kazuaki
    Kita, Mihori
    Yoshimura, Nagahisa
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (06): : 757 - 767
  • [42] Intravitreal Ranibizumab Treatment for Macular Edema Associated with Central Retinal Vein Occlusion and Hemiretinal Vein Occlusion: Cases Reports
    Matias, Joao
    Matos, Rita
    OPHTHALMOLOGICA, 2014, 232 : 74 - 75
  • [43] Intravitreal Injection of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
    Zucchiatti, I.
    Savorgnani, C.
    Veritti, D.
    Parodi, M. Battaglia
    Kontadakis, D. S.
    Papayannis, A.
    Iacono, P.
    Lanzetta, P.
    Bandello, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [44] RESPONSE TO AFLIBERCEPT AS SECONDARY THERAPY IN PATIENTS WITH PERSISTENT RETINAL EDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION INITIALLY TREATED WITH BEVACIZUMAB OR RANIBIZUMAB
    Eadie, James A.
    Ip, Michael S.
    Kulkarni, Amol D.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (12): : 2439 - 2443
  • [45] Efficacy of Intravitreal Bevacizumab Injection for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion
    Celik, Erkan
    Turkoglu, Elif Betul
    Aksoy, Nilgun
    Cakir, Burcin
    Dogan, Emine
    Alagoz, Gursoy
    OPHTHALMOLOGICA, 2014, 232 : 92 - 92
  • [46] Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion
    Giuffre, Chiara
    Cicinelli, Maria Vittoria
    Marchese, Alessandro
    Coppola, Michele
    Parodi, Maurizio Battaglia
    Bandello, Francesco
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (04) : 787 - 793
  • [47] Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion
    Chiara Giuffrè
    Maria Vittoria Cicinelli
    Alessandro Marchese
    Michele Coppola
    Maurizio Battaglia Parodi
    Francesco Bandello
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 787 - 793
  • [48] Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab
    Vasileios Konidaris
    Zahra Al-Hubeshy
    Konstantinos T. Tsaousis
    Konstantina Gorgoli
    Somnath Banerjee
    Theodoros Empeslidis
    International Ophthalmology, 2018, 38 : 207 - 213
  • [49] Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab
    Konidaris, Vasileios
    Al-Hubeshy, Zahra
    Tsaousis, Konstantinos T.
    Gorgoli, Konstantina
    Banerjee, Somnath
    Empeslidis, Theodoros
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (01) : 207 - 213
  • [50] The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
    Gokce, Gokcen
    Sobaci, Gungor
    Durukan, Ali Hakan
    Erdurman, Fazil Cuneyt
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 355 - 362